Showing 2721 results

  • LGBTQI+ inclusion

  • Ad hoc release /

    Novartis Pluvicto™ demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer

    Ad hoc announcement pursuant to Art. 53 LR At interim analysis, PSMAddition trial met its primary endpoint showing statistically significant and clinically meaningful benefit for Pluvicto™…
  • Press release /

    Novartis Kisqali® reduces risk of recurrence in younger patients with early breast cancer in NATALEE subgroup analysis

    33% reduction in relative risk of invasive disease observed in pre-menopausal early breast cancer (EBC) patients receiving Kisqali in 1-year post-treatment analysis1Tolerability remained consistent,…

  • Benefits & Rewards

  • Event /

    ASCO 2025

    At this year’s American Society of Clinical Oncology Annual Meeting (ASCO), we will be sharing the latest oncology portfolio data, research, and science around how we are reimagining medicine.Learn…
  • Press release /

    Novartis announces commencement of tender offer to acquire Regulus Therapeutics

    Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), has commenced a tender offer to…
  • Featured News /

    Novartis R&D Day

    Novartis shares progress in advancing its industry-leading R&D pipeline. We are uniquely positioned to deliver transformational treatments through our scale, focus on innovative medicines, diverse range of therapeutic areas and exposure to cutting-edge platforms.

  • The Program lead of ‘Ensemble’ sitting with a Novartis employee and caregiver
    Story /

    Reimagining cancer in the workplace

    Novartis is strongly committed in helping and supporting employees impacted by cancer through the program Ensemble – Caring for Colleagues (Ensemble).

    People and Culture
  • Special Olympian Ryan Groves suffers from TSC, a genetic condition that afflicts nearly 1 million patients worldwide.
    Story /

    With a "brain in a dish," researchers take on neurological disorders

    Neurological diseases develop out of sight. Novartis neuroscientists are bringing them into the light, using human brain cells grown in the lab.

    From Our Labs
  • Dr. Botond Roska shares his thoughts on the future of gene therapy.
    Story /

    Bringing gene therapy into focus

    Dr. Botond Roska says we should keep our eyes on gene therapy.

    Discovery